• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Degeneration of pyramidal projection neurons in Huntington's disease cortex.

作者信息

Cudkowicz M, Kowall N W

机构信息

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.

出版信息

Ann Neurol. 1990 Feb;27(2):200-4. doi: 10.1002/ana.410270217.

DOI:10.1002/ana.410270217
PMID:2138444
Abstract

We examined the distribution of neuropeptide Y immunoreactive local circuit neurons and nonphosphorylated neurofilament (SMI 32) immunoreactive pyramidal projection neurons in superior frontal cortex of patients with Huntington's disease and age-matched control subjects to determine the histological counterpart of increased neuropeptide Y and decrease glutamate concentrations previously found in the cortex of patients with Huntington's disease. We found no difference between the relative density of neuropeptide Y neurons in Huntington's disease and control brains in regions where the relative density of SMI 32 immunoreactive was significantly reduced. Animal studies show that cortical local circuit neurons are resistant to N-methyl-D-aspartate-type excitotoxins such as quinolinic acid. Relative sparing of neuropeptide Y neurons in cerebral cortex with Huntington's disease may, therefore, be a result of excessive N-methyl-D-aspartate receptor activation.

摘要

相似文献

1
Degeneration of pyramidal projection neurons in Huntington's disease cortex.
Ann Neurol. 1990 Feb;27(2):200-4. doi: 10.1002/ana.410270217.
2
The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex.亨廷顿病的皮质病变:进一步的神经化学特征,以及大鼠皮质N-甲基-D-天冬氨酸损伤对某些组织学和神经化学特征的重现。
Ann Neurol. 1992 Oct;32(4):526-34. doi: 10.1002/ana.410320408.
3
Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.纹状体兴奋性毒素损伤后生长抑素-神经肽Y和胆碱能神经元的差异保留
Synapse. 1989;3(1):38-47. doi: 10.1002/syn.890030106.
4
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease.亨廷顿病病理分级病例中生长抑素和神经肽Y的浓度
Ann Neurol. 1988 Jun;23(6):562-9. doi: 10.1002/ana.410230606.
5
Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.运动和扣带皮层的细胞丢失与亨廷顿病的症状相关。
Brain. 2010 Apr;133(Pt 4):1094-110. doi: 10.1093/brain/awq047.
6
Cortical peptide changes in Huntington's disease may be independent of striatal degeneration.亨廷顿舞蹈病中皮质肽的变化可能与纹状体变性无关。
Ann Neurol. 1997 Apr;41(4):540-7. doi: 10.1002/ana.410410418.
7
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中纹状体多巴胺能神经元的命运。
Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2.
8
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid.
Nature. 1986;321(6066):168-71. doi: 10.1038/321168a0.
9
Huntington's disease: changes in tachykinin content in postmortem brains.
Ann Neurol. 1987 Nov;22(5):587-94. doi: 10.1002/ana.410220505.
10
Evidence for progression in frontal cortical pathology in late-stage Huntington's disease.晚期亨廷顿舞蹈症患者额叶皮质病理进展的证据。
J Comp Neurol. 2004 Jan 6;468(2):190-204. doi: 10.1002/cne.10938.

引用本文的文献

1
Neuron-derived extracellular vesicles in plasma present a potential non-invasive biomarker for Huntingtin protein and RNA assessment in Huntington disease.血浆中神经元衍生的细胞外囊泡是一种潜在的非侵入性生物标志物,可用于评估亨廷顿舞蹈病中的亨廷顿蛋白和RNA。
bioRxiv. 2025 Jul 21:2025.07.17.665403. doi: 10.1101/2025.07.17.665403.
2
Cerulenin partially corrects the disrupted developmental transcriptomic signature in Huntington's disease striatal medium spiny neurons.浅蓝菌素可部分纠正亨廷顿舞蹈病纹状体中等棘状神经元中紊乱的发育转录组特征。
Stem Cells. 2025 Jul 21;43(8). doi: 10.1093/stmcls/sxaf029.
3
Break-up and recovery of harmony between direct and indirect pathways in the basal ganglia: Huntington's disease and treatment.
基底神经节中直接和间接通路之间协调的破坏与恢复:亨廷顿舞蹈症与治疗
Cogn Neurodyn. 2024 Oct;18(5):2909-2924. doi: 10.1007/s11571-024-10125-w. Epub 2024 May 30.
4
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.血浆和脑脊液神经丝轻链浓度升高在亨廷顿病小鼠的大脑中响应于突变亨廷顿蛋白降低而稳定。
Transl Neurodegener. 2024 Oct 8;13(1):50. doi: 10.1186/s40035-024-00443-8.
5
Nebulization of low-dose aspirin ameliorates Huntington's pathology in N171-82Q transgenic mice.低剂量阿司匹林雾化吸入可改善N171-82Q转基因小鼠的亨廷顿氏病理症状。
NeuroImmune Pharm Ther. 2024 Feb 9;3(1):47-59. doi: 10.1515/nipt-2023-0026. eCollection 2024 Mar.
6
Synaptic alterations and neuronal firing in human epileptic neocortical excitatory networks.人类癫痫性新皮质兴奋性网络中的突触改变与神经元放电
Front Synaptic Neurosci. 2023 Aug 10;15:1233569. doi: 10.3389/fnsyn.2023.1233569. eCollection 2023.
7
Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.用于评估亨廷顿病发病和严重程度的脑脊液生物标志物。
Brain Commun. 2022 Nov 25;4(6):fcac309. doi: 10.1093/braincomms/fcac309. eCollection 2022.
8
Distinct histological alterations of cortical interneuron types in mouse models of Huntington's disease.亨廷顿舞蹈症小鼠模型中皮质中间神经元类型的不同组织学改变。
Front Neurosci. 2022 Sep 26;16:1022251. doi: 10.3389/fnins.2022.1022251. eCollection 2022.
9
Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.亨廷顿舞蹈症诱导多能干细胞模型——利用人类患者细胞来了解由CAG重复序列扩增所导致的病理状况。
Fac Rev. 2022 Jun 28;11:16. doi: 10.12703/r/11-16. eCollection 2022.
10
Epigenomic Remodeling in Huntington's Disease-Master or Servant?亨廷顿舞蹈病中的表观基因组重塑:主因还是从属因素?
Epigenomes. 2020 Jul 31;4(3):15. doi: 10.3390/epigenomes4030015.